MRI/MRS evaluation of a female carrier of Duchenne muscular dystrophy

被引:19
作者
Forbes, Sean C.
Lott, Donovan J.
Finkel, Richard S. [2 ]
Senesac, Claudia
Byrne, Barry J. [3 ,4 ]
Sweeney, H. Lee [5 ]
Walter, Glenn A. [6 ]
Vandenborne, Krista [1 ]
机构
[1] Univ Florida, Dept Phys Therapy, UFHSC, Gainesville, FL 32610 USA
[2] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA
[3] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA
[4] Univ Florida, Powell Gene Therapy Ctr, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
[5] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA
[6] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA
关键词
Female carrier; Duchenne muscular dystrophy; Magnetic resonance imaging; Magnetic resonance spectroscopy; Skeletal muscle; Biomarker; 6-MINUTE WALK TEST; RELAXATION-TIMES; SKELETAL-MUSCLE; MANIFESTING CARRIER; MRI; EXERCISE; TISSUE; DAMAGE; BOYS; AGE;
D O I
10.1016/j.nmd.2012.05.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to evaluate skeletal muscle composition of lower extremity muscles in a manifesting female carrier of Duchenne muscular dystrophy (MFCDMD) using magnetic resonance imaging (MRI) and spectroscopy (MRS). MRI/MRS was performed on the lower extremities and heart of a MFCDMD (47 years, 51 kg) on four occasions within 21 months and in a control subject. Heterogeneity and asymmetry among muscles in the MFCDMD was observed in lipid fraction and mean transverse relaxation time (T-2) of lower extremity muscles with some muscles presenting as unaffected (e.g., rectus femoris) and others showing substantial deterioration and lipid infiltration (e.g., vasti muscles). There was an association of abnormal MRI findings and strength and motor function. Over the 21 months a small decrease in CSA(max) and increase in lipid fraction and T-2 was observed in the MFCDMD in some muscles. In summary, this MFCDMD revealed significant imaging evidence of pathologic heterogeneity among muscles. Furthermore, this study shows the feasibility of combining various quantitative MRI and MRS approaches to monitor skeletal muscle involvement. Published by Elsevier B.V.
引用
收藏
页码:S111 / S121
页数:11
相关论文
共 50 条
  • [41] The Immune System in Duchenne Muscular Dystrophy Pathogenesis
    Tripodi, Luana
    Villa, Chiara
    Molinaro, Davide
    Torrente, Yvan
    Farini, Andrea
    BIOMEDICINES, 2021, 9 (10)
  • [42] Duchenne muscular dystrophy: current cell therapies
    Sienkiewicz, Dorota
    Kulak, Wojciech
    Okurowska-Zawada, Bozena
    Paszko-Patej, Grazyna
    Kawnik, Katarzyna
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (04) : 166 - 177
  • [43] Magnetic resonance imaging of the proximal upper extremity musculature in boys with Duchenne muscular dystrophy
    Willcocks, R. J.
    Triplett, W. T.
    Forbes, S. C.
    Arora, H.
    Senesac, C. R.
    Lott, D. J.
    Nicholson, T. R.
    Rooney, W. D.
    Walter, G. A.
    Vandenborne, K.
    JOURNAL OF NEUROLOGY, 2017, 264 (01) : 64 - 71
  • [44] Role of proteoglycans and glycosaminoglycans in Duchenne muscular dystrophy
    Carmen, Laurino
    Maria, Vadala'
    Cesar Morales-Medina, Julio
    Vallelunga, Annamaria
    Palmieri, Beniamino
    Iannitti, Tommaso
    GLYCOBIOLOGY, 2019, 29 (02) : 110 - 123
  • [45] Drug Discovery of Therapies for Duchenne Muscular Dystrophy
    Blat, Yuval
    Blat, Shachar
    JOURNAL OF BIOMOLECULAR SCREENING, 2015, 20 (10) : 1189 - 1203
  • [46] miRNAs as serum biomarkers for Duchenne muscular dystrophy
    Cacchiarelli, Davide
    Legnini, Ivano
    Martone, Julie
    Cazzella, Valentina
    D'Amico, Adele
    Bertini, Enrico
    Bozzoni, Irene
    EMBO MOLECULAR MEDICINE, 2011, 3 (05) : 258 - 265
  • [47] Current Pharmacological Strategies for Duchenne Muscular Dystrophy
    Yao, Shanshan
    Chen, Zihao
    Yu, Yuanyuan
    Zhang, Ning
    Jiang, Hewen
    Zhang, Ge
    Zhang, Zongkang
    Zhang, Baoting
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [48] Uncovering the Embryonic Origins of Duchenne Muscular Dystrophy
    Barrett, Philip
    Louie, Ke'ale W.
    Dupont, Jean-Baptiste
    Mack, David L.
    Maves, Lisa
    WIRES MECHANISMS OF DISEASE, 2024, 16 (06):
  • [49] The Role of MicroRNA in the Pathogenesis of Duchenne Muscular Dystrophy
    Kielbowski, Kajetan
    Bakinowska, Estera
    Procyk, Grzegorz
    Zietara, Marta
    Pawlik, Andrzej
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [50] Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
    Sun, Chengmei
    Shen, Luoan
    Zhang, Zheng
    Xie, Xin
    GENES, 2020, 11 (08) : 1 - 25